nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis
|
Kim, Hong-Bae |
|
|
78 |
Suppl 1 |
p. 383-391 |
artikel |
2 |
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
|
Söderman, Lisa |
|
|
78 |
Suppl 1 |
p. 191-196 |
artikel |
3 |
Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus
|
Aung, Ar Kar |
|
|
78 |
Suppl 1 |
p. 781-791 |
artikel |
4 |
Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy
|
Yao, Nannan |
|
|
78 |
Suppl 1 |
p. 1667-1675 |
artikel |
5 |
Antihypertensive prescribing pattern, prescriber adherence to ISH 2020 guidelines, and implication of outpatient drug price on blood pressure control at selected hospitals in Southern Ethiopia
|
Sorato, Mende Mensa |
|
|
78 |
Suppl 1 |
p. 1487-1502 |
artikel |
6 |
Applying pharmacokinetic/pharmacodynamic measurements for linezolid in critically ill patients: optimizing efficacy and reducing resistance occurrence
|
El-Gaml, Rasha M. |
|
|
78 |
Suppl 1 |
p. 1301-1310 |
artikel |
7 |
Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease
|
Yi, Mengshi |
|
|
78 |
Suppl 1 |
p. 647-656 |
artikel |
8 |
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study
|
Guan, Ziwan |
|
|
78 |
Suppl 1 |
p. 793-799 |
artikel |
9 |
Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia
|
Yaowaluk, Thitipon |
|
|
78 |
Suppl 1 |
p. 1249-1259 |
artikel |
10 |
Attitudes and beliefs of older adults and caregivers towards deprescribing in French-speaking countries: a multicenter cross-sectional study
|
Roux, Barbara |
|
|
78 |
Suppl 1 |
p. 1633-1646 |
artikel |
11 |
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
|
Vallius, Sanna |
|
|
78 |
Suppl 1 |
p. 513-521 |
artikel |
12 |
Bevacizumab and aflibercept in second-line metastatic colorectal cancer: 12 years of experience
|
Claramunt García, Raquel |
|
|
78 |
Suppl 1 |
p. 287-291 |
artikel |
13 |
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma
|
Nath, Christa Ellen |
|
|
78 |
Suppl 1 |
p. 1911-1921 |
artikel |
14 |
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
|
Yekedüz, Emre |
|
|
78 |
Suppl 1 |
p. 1973-1979 |
artikel |
15 |
Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults
|
Zhou, Zhen |
|
|
78 |
Suppl 1 |
p. 467-476 |
artikel |
16 |
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway
|
Gedde-Dahl, Ane |
|
|
78 |
Suppl 1 |
p. 1623-1632 |
artikel |
17 |
Correction to: Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?
|
Du, Lixin |
|
|
78 |
Suppl 1 |
p. 1705 |
artikel |
18 |
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range
|
Eide Kvitne, Kine |
|
|
78 |
Suppl 1 |
p. 1289-1299 |
artikel |
19 |
Different interventions for preventing postoperative catheter-related bladder discomfort: a systematic review and meta-analysis
|
Li, Shuying |
|
|
78 |
Suppl 1 |
p. 897-906 |
artikel |
20 |
Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data
|
Hu, Wei |
|
|
78 |
Suppl 1 |
p. 1057-1067 |
artikel |
21 |
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis
|
Ma, Shaodi |
|
|
78 |
Suppl 1 |
p. 1403-1420 |
artikel |
22 |
Does ramadan fasting affect the therapeutic and clinical outcomes of warfarin? a systematic review and meta-analysis
|
Rabea, Eslam Mohammed |
|
|
78 |
Suppl 1 |
p. 755-763 |
artikel |
23 |
Effectiveness and safety of gonadotropins used in female infertility: a population-based study in the Lazio region, Italy
|
Rosa, Alessandro Cesare |
|
|
78 |
Suppl 1 |
p. 1185-1196 |
artikel |
24 |
Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin
|
Xia, Xiaotong |
|
|
78 |
Suppl 1 |
p. 205-214 |
artikel |
25 |
Effect of GLP-1R rs2254336 and rs3765467 polymorphisms on gastrointestinal adverse reactions in type 2 diabetes patients treated with liraglutide
|
Long, Jiangchuan |
|
|
78 |
Suppl 1 |
p. 589-596 |
artikel |
26 |
Effect of posaconazole on the concentration of intravenous and oral cyclosporine in patients undergoing hematopoietic stem cell transplantation
|
Zhu, Li-E |
|
|
78 |
Suppl 1 |
p. 1677-1685 |
artikel |
27 |
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib
|
Maeda, Akimitsu |
|
|
78 |
Suppl 1 |
p. 1239-1247 |
artikel |
28 |
Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials
|
Bao, Wujisiguleng |
|
|
78 |
Suppl 1 |
p. 1877-1887 |
artikel |
29 |
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials
|
Martins-Filho, Paulo Ricardo |
|
|
78 |
Suppl 1 |
p. 1813-1821 |
artikel |
30 |
Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence
|
Borovac, Josip A. |
|
|
78 |
Suppl 1 |
p. 111-126 |
artikel |
31 |
Estimation of cefepime, piperacillin, and tazobactam clearance with iohexol-based glomerular filtration rate in paediatric patients
|
Soeorg, Hiie |
|
|
78 |
Suppl 1 |
p. 989-1001 |
artikel |
32 |
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis
|
Zhang, Lingxiao |
|
|
78 |
Suppl 1 |
p. 1421-1434 |
artikel |
33 |
Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans
|
Elbe, Annika |
|
|
78 |
Suppl 1 |
p. 975-987 |
artikel |
34 |
Evaluation of drug interactions of saxagliptin with sildenafil in healthy volunteers
|
Mansour, Rania Y. |
|
|
78 |
Suppl 1 |
p. 1935-1944 |
artikel |
35 |
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant
|
Hibino, Hideyuki |
|
|
78 |
Suppl 1 |
p. 613-621 |
artikel |
36 |
Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites
|
Liu, Zheng |
|
|
78 |
Suppl 1 |
p. 53-64 |
artikel |
37 |
Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review
|
Rathinam, Kiran Kumar |
|
|
78 |
Suppl 1 |
p. 531-545 |
artikel |
38 |
Evaluation of serum levels of asprosin and other metabolic profiles in patients with idiopathic tonic–clonic generalized epilepsy on treatment with valproic acid
|
Yaryari, Amir-mohammad |
|
|
78 |
Suppl 1 |
p. 393-403 |
artikel |
39 |
Evaluation of two European risk models for predicting medication harm in an Australian patient cohort
|
Falconer, Nazanin |
|
|
78 |
Suppl 1 |
p. 679-686 |
artikel |
40 |
Evaluation of vatiquinone drug-drug interaction potential in vitro and in a phase 1 clinical study with tolbutamide, a CYP2C9 substrate, and omeprazole, a CYP2C19 substrate, in healthy subjects
|
Murase, Katsuyuki |
|
|
78 |
Suppl 1 |
p. 1823-1831 |
artikel |
41 |
Exploring heterogeneities of cardiovascular efficacy and effectiveness of SGLT2 inhibitors in patients with type 2 diabetes: an umbrella review of evidence from randomized clinical trials versus real-world observational studies
|
Seo, Bojung |
|
|
78 |
Suppl 1 |
p. 1205-1216 |
artikel |
42 |
Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study
|
Zhang, Chi |
|
|
78 |
Suppl 1 |
p. 293-304 |
artikel |
43 |
Feasibility study and evaluation of expert opinion on the semi-automated meta-analysis and the conventional meta-analysis
|
Ajiji, Priscilla |
|
|
78 |
Suppl 1 |
p. 1177-1184 |
artikel |
44 |
Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use
|
Mattioli, Irene |
|
|
78 |
Suppl 1 |
p. 1511-1519 |
artikel |
45 |
Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage
|
Silva, Lunara Teles |
|
|
78 |
Suppl 1 |
p. 435-466 |
artikel |
46 |
Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis
|
de Macedo Andrade, Ana Cláudia |
|
|
78 |
Suppl 1 |
p. 919-930 |
artikel |
47 |
Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entity
|
Trenque, Thierry |
|
|
78 |
Suppl 1 |
p. 687-690 |
artikel |
48 |
Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients
|
Abe, Kazuki |
|
|
78 |
Suppl 1 |
p. 77-87 |
artikel |
49 |
Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity
|
González-Bueno, J. |
|
|
78 |
Suppl 1 |
p. 127-137 |
artikel |
50 |
Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study
|
Sharon, Reeha |
|
|
78 |
Suppl 1 |
p. 1341-1349 |
artikel |
51 |
Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies
|
Bagepally, Bhavani Shankara |
|
|
78 |
Suppl 1 |
p. 351-363 |
artikel |
52 |
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients
|
Preijers, T. |
|
|
78 |
Suppl 1 |
p. 237-249 |
artikel |
53 |
Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study
|
Gur, Sultan Tuna Akgol |
|
|
78 |
Suppl 1 |
p. 27-33 |
artikel |
54 |
Investigation of pharmacokinetic and clinical outcomes of various meropenem regimens in patients with ventilator-associated pneumonia and augmented renal clearance
|
Razzazzadeh, Sareh |
|
|
78 |
Suppl 1 |
p. 823-829 |
artikel |
55 |
Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational study
|
Tsutsumi, Takezo |
|
|
78 |
Suppl 1 |
p. 279-286 |
artikel |
56 |
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
|
Gouverneur, Amandine |
|
|
78 |
Suppl 1 |
p. 1981-1990 |
artikel |
57 |
Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma
|
Xu, Bo |
|
|
78 |
Suppl 1 |
p. 707-719 |
artikel |
58 |
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study
|
Merćep, Iveta |
|
|
78 |
Suppl 1 |
p. 227-236 |
artikel |
59 |
Low-dose lidocaine attenuates fentanyl-induced cough: A double-blind randomized controlled trial
|
Phuvachoterojanaphokin, Nuanwan |
|
|
78 |
Suppl 1 |
p. 813-821 |
artikel |
60 |
Man vs. machine: comparison of pharmacogenetic expert counselling with a clinical medication support system in a study with 200 genotyped patients
|
Preissner, Sally H. |
|
|
78 |
Suppl 1 |
p. 579-587 |
artikel |
61 |
Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis
|
Ying, Xian-hua |
|
|
78 |
Suppl 1 |
p. 171-180 |
artikel |
62 |
Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol
|
Pedersen, Elisabeth |
|
|
78 |
Suppl 1 |
p. 857-867 |
artikel |
63 |
Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid
|
Cheng, Lin |
|
|
78 |
Suppl 1 |
p. 1227-1238 |
artikel |
64 |
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene
|
Nielsen, David A. |
|
|
78 |
Suppl 1 |
p. 965-973 |
artikel |
65 |
Neonatal outcomes after gamma-aminobutyric acid analog use during pregnancy: a meta-analysis of cohort studies
|
Jin, Xi-long |
|
|
78 |
Suppl 1 |
p. 1739-1747 |
artikel |
66 |
No association between acid suppressant use and risk of dementia: an updated meta-analysis
|
Wang, Hengmin |
|
|
78 |
Suppl 1 |
p. 375-382 |
artikel |
67 |
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers
|
Breithaupt, Mareile H. |
|
|
78 |
Suppl 1 |
p. 1965-1972 |
artikel |
68 |
Pharmacokinetics of benapenem for injection in subjects with mild to moderate renal impairment
|
Yang, Haijing |
|
|
78 |
Suppl 1 |
p. 1079-1086 |
artikel |
69 |
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study
|
Peters, Erica N. |
|
|
78 |
Suppl 1 |
p. 259-265 |
artikel |
70 |
Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus
|
Beaulieu, Quentin |
|
|
78 |
Suppl 1 |
p. 1003-1010 |
artikel |
71 |
Pharmacological interventions for preventing atrial fibrillation after lung surgery: systematic review and meta-analysis
|
Wang, Xiaomei |
|
|
78 |
Suppl 1 |
p. 1777-1790 |
artikel |
72 |
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment
|
Watanabe, Akiko |
|
|
78 |
Suppl 1 |
p. 65-73 |
artikel |
73 |
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib
|
Adiwidjaja, Jeffry |
|
|
78 |
Suppl 1 |
p. 597-611 |
artikel |
74 |
Population pharmacokinetics of cefotaxime in intensive care patients
|
Swartling, Maria |
|
|
78 |
Suppl 1 |
p. 251-258 |
artikel |
75 |
Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy
|
Michaličková, Danica |
|
|
78 |
Suppl 1 |
p. 89-98 |
artikel |
76 |
Potentially inappropriate medication use and mortality in patients with cognitive impairment
|
Buckley, Emily |
|
|
78 |
Suppl 1 |
p. 2013-2020 |
artikel |
77 |
Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study
|
Varavithya, Vorawee |
|
|
78 |
Suppl 1 |
p. 847-855 |
artikel |
78 |
Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation
|
Carbone, Andreina |
|
|
78 |
Suppl 1 |
p. 879-886 |
artikel |
79 |
Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study
|
Sundvall, Helena |
|
|
78 |
Suppl 1 |
p. 1459-1467 |
artikel |
80 |
Prevalence and patient-rated relevance of complexity factors in medication regimens of community-dwelling patients with polypharmacy
|
Wurmbach, Viktoria S. |
|
|
78 |
Suppl 1 |
p. 1127-1136 |
artikel |
81 |
Proton pump inhibitors and osteoporosis risk: exploring the role of TRPM7 channel
|
Desai, Bhargavi V. |
|
|
78 |
Suppl 1 |
p. 35-41 |
artikel |
82 |
Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries
|
Kindstedt, Jonas |
|
|
78 |
Suppl 1 |
p. 477-487 |
artikel |
83 |
Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis
|
Dai, Jianfeng |
|
|
78 |
Suppl 1 |
p. 1727-1737 |
artikel |
84 |
Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis
|
Lee, Seoyeon |
|
|
78 |
Suppl 1 |
p. 1365-1376 |
artikel |
85 |
Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma
|
Lai, Shih-Wei |
|
|
78 |
Suppl 1 |
p. 1197-1198 |
artikel |
86 |
Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants
|
Bhagavathula, Akshaya Srikanth |
|
|
78 |
Suppl 1 |
p. 547-555 |
artikel |
87 |
Sports nutrition supplements and adverse events – a meta-epidemiological study of case reports specifically addressing causality assessment
|
Zeijlon, Rickard |
|
|
78 |
Suppl 1 |
p. 1-9 |
artikel |
88 |
Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis
|
Mu, Guangyan |
|
|
78 |
Suppl 1 |
p. 181-190 |
artikel |
89 |
Statin discontinuation in persons with and without Alzheimer’s disease
|
Vu, Mai |
|
|
78 |
Suppl 1 |
p. 1145-1153 |
artikel |
90 |
Stereoselective interaction of tolvaptan with amiodarone under racemic metabolic impact by CYP3A5 genotypes in heart failure patients
|
Akutsu, Shunta |
|
|
78 |
Suppl 1 |
p. 1311-1320 |
artikel |
91 |
The association between the availability of over the counter codeine and the prevalence of non-medical use
|
Hockenhull, Joanna |
|
|
78 |
Suppl 1 |
p. 1011-1018 |
artikel |
92 |
The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study
|
Müller, Fabian |
|
|
78 |
Suppl 1 |
p. 801-812 |
artikel |
93 |
The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers
|
Schneider, F. |
|
|
78 |
Suppl 1 |
p. 11-18 |
artikel |
94 |
The effect of preoperative statin treatment on acute kidney injury in elderly patients undergoing valve replacement surgery
|
Fu, Bing-qi |
|
|
78 |
Suppl 1 |
p. 505-512 |
artikel |
95 |
The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study
|
Elshafei, Mohamed Nabil |
|
|
78 |
Suppl 1 |
p. 1801-1811 |
artikel |
96 |
The impact of omega-3 polyunsaturated fatty acids on primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials
|
Mohammadi, Mohammad Mehdi |
|
|
78 |
Suppl 1 |
p. 721-731 |
artikel |
97 |
The impact of PIPs on mortality and readmissions in older adults: a retrospective cohort study
|
Pardo-Cabello, Alfredo Jose |
|
|
78 |
Suppl 1 |
p. 139-145 |
artikel |
98 |
The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients
|
Wang, Xi-Han |
|
|
78 |
Suppl 1 |
p. 1261-1272 |
artikel |
99 |
Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey
|
Jaspers, Tessa Corrine Catherina |
|
|
78 |
Suppl 1 |
p. 1469-1479 |
artikel |
100 |
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
|
Alves, Carlos |
|
|
78 |
Suppl 1 |
p. 1923-1933 |
artikel |
101 |
To establish a model for the prediction of initial standard and maintenance doses of warfarin for the Han Chinese population based on gene polymorphism: a multicenter study
|
Xia, Xiaotong |
|
|
78 |
Suppl 1 |
p. 43-51 |
artikel |
102 |
Trends and variation in benzodiazepine use in nursing homes in the USA
|
Malagaris, Ioannis |
|
|
78 |
Suppl 1 |
p. 489-496 |
artikel |
103 |
Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study
|
García Rodríguez, Luis A. |
|
|
78 |
Suppl 1 |
p. 497-504 |
artikel |
104 |
Updated network meta-analysis assessing the relative efficacy of 13 GLP-1 RA and SGLT2 inhibitor interventions on cardiorenal and mortality outcomes in type 2 diabetes
|
Qiu, Mei |
|
|
78 |
Suppl 1 |
p. 695-697 |
artikel |
105 |
Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies
|
Yang, Jiang |
|
|
78 |
Suppl 1 |
p. 365-373 |
artikel |
106 |
Use of a long-acting substitute in detoxification from benzodiazepines: safety (accumulation) problems and proposed mitigation procedure
|
Basińska-Szafrańska, Anna |
|
|
78 |
Suppl 1 |
p. 1833-1841 |
artikel |
107 |
Use of tramadol and the risk of bleeding complications in patients on oral anticoagulants: a systematic review and meta-analysis
|
Lévy, Clara |
|
|
78 |
Suppl 1 |
p. 1889-1898 |
artikel |
108 |
Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China
|
Lyu, Si-qi |
|
|
78 |
Suppl 1 |
p. 215-225 |
artikel |
109 |
Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
|
Li, Raymond |
|
|
78 |
Suppl 1 |
p. 1165-1175 |
artikel |
110 |
Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic
|
Russo, Selena |
|
|
78 |
Suppl 1 |
p. 1791-1800 |
artikel |